Atorvastatin Reduces Expression of the CCR2 and MAC-1 Receptors on Monocytes, and Plasma Levels of Monocyte Chemoattractant Protein-1 and C-Reactive Protein, in Patients with Coronary Heart Disease

By Fernández-Cruz A.  

Clinical Drug Investigation, Vol. 22, Iss. 1, 2002-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Analide derivatives as monocyte chemoattractant protein-1 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 711-715

Informa Healthcare

Access to resources Recommend Favorite

Targeting monocyte chemoattractant protein-1 signalling in disease

By Dawson Janet   Miltz Wolfgang   Mir Anis K   Wiessner Christoph  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 1, 2003-02 ,pp. : 35-48

Informa Healthcare

Access to resources Recommend Favorite

CCR1 and CCR2 Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1539-1552

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite